News and Trends 1 Sep 2017
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer's disease. A year ago, Allergan signed a massive deal of up…